CeNeRx BioPharma Obtains Rights To Novel Drug Candidate For Prevention And Treatment Of Neurodegeneration Disorders
Medical News Today, Article Date: 17 Jun 2009 - 3:00 PDT
Full Text: http://www.medicalnewstoday.com/articles/154197.php
Keywords: central nervous system , neuropathies, neurodegenerative disorders, CXB909, nerve growth factor (NGF), Phase l trial , blood brain barrier.
Press realease of CeNeRx Biopharma: http://cenerx.com/News/releases/16a-JUN-09.pdf
Subscribe to:
Posts (Atom)
